Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure

NCT01218464 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Liver Failure
Mesenchymal Stem Cells

Interventions

DRUG: Conventional plus MSC treatment
DRUG: Conventional plus pacebo treatment

Sponsor

Beijing 302 Hospital